{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:54Z","timestamp":1772119554411,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10620-024-08364-2","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T14:01:43Z","timestamp":1710597703000},"page":"1803-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"69","author":[{"given":"Chelsea A.","family":"DeBolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zo\u00eb S.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasa G.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaelyn","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Rekawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Meislin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Berkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Mella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marla C.","family":"Dubinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"key":"8364_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/apt.12412","volume":"38","author":"N Pedersen","year":"2013","unstructured":"Pedersen N, Bortoli A, Duricova D et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38:501\u2013512.","journal-title":"Aliment Pharmacol Ther."},{"key":"8364_CR2","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/1471-0528.13946","volume":"123","author":"AW Shand","year":"2016","unstructured":"Shand AW, Chen JS, Selby W, Solomon M, Roberts CL. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes. BJOG. 2016;123:1862\u20131870.","journal-title":"BJOG."},{"key":"8364_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","volume":"156","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, Higuchi LM, Huang ES et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350\u2013359.","journal-title":"Ann Intern Med."},{"key":"8364_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00535-008-2206-5","volume":"43","author":"A Shiotani","year":"2008","unstructured":"Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol. 2008;43:581\u2013588.","journal-title":"J Gastroenterol."},{"key":"8364_CR5","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","volume":"95","author":"JB Felder","year":"2000","unstructured":"Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95:1949\u20131954.","journal-title":"Am J Gastroenterol."},{"key":"8364_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ibd\/izaa060","volume":"27","author":"P Patel","year":"2021","unstructured":"Patel P, Gao G, Gulotta G et al. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021;27:236\u2013241.","journal-title":"Inflamm Bowel Dis."},{"key":"8364_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jama.2021.14781","volume":"326","author":"KW Davidson","year":"2021","unstructured":"US Preventive Services Task Force, Davidson KW, Barry MJ et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. JAMA 2021;326:1186\u20131191.","journal-title":"JAMA"},{"key":"8364_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129567","volume":"10","author":"HA Boyd","year":"2015","unstructured":"Boyd HA, Basit S, Harps\u00f8e MC, Wohlfahrt J, Jess T. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes. PLoS ONE 2015;10:e0129567.","journal-title":"PLoS ONE"},{"key":"8364_CR9","doi-asserted-by":"crossref","unstructured":"Yu A, Fenton CL, Wen T, Irani RA, Mahadevan, U. The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals with Inflammatory Bowel Disease. Presented at American College of Gastroenterology Annual Scientific Meeting, October 2023. [Abstract].","DOI":"10.14309\/01.ajg.0000953000.08478.8a"},{"key":"8364_CR10","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.14309\/ajg.0000000000001932","volume":"117","author":"S Cohen-Mekelburg","year":"2022","unstructured":"Cohen-Mekelburg S, Van T, Wallace B et al. The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias? Am J Gastroenterol. 2022;117:1851\u20131857.","journal-title":"Am J Gastroenterol."},{"key":"8364_CR11","doi-asserted-by":"publisher","unstructured":"ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018 Jul;132:e44\u2013e52. https:\/\/doi.org\/10.1097\/AOG.0000000000002708. PMID: 29939940","DOI":"10.1097\/AOG.0000000000002708"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08364-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08364-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08364-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:03:25Z","timestamp":1720094605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08364-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["8364"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08364-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3879481\/v1","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,16]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MCD is a consultant for the following: Abbvie, Abivax, Arena Pharmaceuticals, Astra Zeneca, Boehringer Ingelheim International GmbH, Bristol-Meyer Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genentech Inc, Gilead, Janssen Pharmaceuticals, Merck, Pfizer Inc, Prometheus Biosciences, Takeda Pharmaceuticals. The authors otherwise have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}